Literature DB >> 19891548

Can the pharmacogenetics of GST gene polymorphisms predict the dose of busulfan in pediatric hematopoietic stem cell transplantation?

Marc Ansari, Maja Krajinovic.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19891548     DOI: 10.2217/pgs.09.135

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  6 in total

1.  Effect of weight and maturation on busulfan clearance in infants and small children undergoing hematopoietic cell transplantation.

Authors:  Radojka M Savic; Morton J Cowan; Christopher C Dvorak; Sung-Yun Pai; Luis Pereira; Imke H Bartelink; Jaap J Boelens; Robbert G M Bredius; Rob F Wynn; Geoff D E Cuvelier; Peter J Shaw; Mary A Slatter; Janel Long-Boyle
Journal:  Biol Blood Marrow Transplant       Date:  2013-09-09       Impact factor: 5.742

2.  Population pharmacokinetics of busulfan in pediatric and young adult patients undergoing hematopoietic cell transplant: a model-based dosing algorithm for personalized therapy and implementation into routine clinical use.

Authors:  Janel R Long-Boyle; Rada Savic; Shirley Yan; Imke Bartelink; Lisa Musick; Deborah French; Jason Law; Biljana Horn; Morton J Cowan; Christopher C Dvorak
Journal:  Ther Drug Monit       Date:  2015-04       Impact factor: 3.681

3.  Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome After Myeloablative Conditioning.

Authors:  Sara Bremer; Yngvar Fløisand; Lorentz Brinch; Tobias Gedde-Dahl; Stein Bergan
Journal:  Ther Drug Monit       Date:  2015-08       Impact factor: 3.681

4.  Assessment of a Model-Informed Precision Dosing Platform Use in Routine Clinical Care for Personalized Busulfan Therapy in the Pediatric Hematopoietic Cell Transplantation (HCT) Population.

Authors:  Praveen Shukla; Srijib Goswami; Ron J Keizer; Beth Apsel Winger; Sandhya Kharbanda; Christopher C Dvorak; Janel Long-Boyle
Journal:  Front Pharmacol       Date:  2020-07-02       Impact factor: 5.810

5.  Comparison of Two Analytical Methods for Busulfan Therapeutic Drug Monitoring.

Authors:  Simona De Gregori; Carmine Tinelli; Federica Manzoni; Antonella Bartoli
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-01       Impact factor: 2.441

6.  A semi-mechanistic model based on glutathione depletion to describe intra-individual reduction in busulfan clearance.

Authors:  Jurgen B Langenhorst; Jill Boss; Charlotte van Kesteren; Arief Lalmohamed; Jürgen Kuball; Antoine C G Egberts; Jaap Jan Boelens; Alwin D R Huitema; Erik M van Maarseveen
Journal:  Br J Clin Pharmacol       Date:  2020-03-10       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.